Vitamin Shoppe, Inc (VSI) Stock Price Up -5.7%

Vitamin Shoppe, Inc (NYSE:VSI) shares rose 5.7% during mid-day trading on Friday . The company traded as high as $5.95 and last traded at $5.38. Approximately 234,722 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 644,627 shares. The stock had previously closed at $5.70.

A number of analysts have issued reports on VSI shares. Morgan Stanley raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price target for the company in a report on Thursday, May 11th. Gabelli downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a report on Saturday, May 13th. Barclays PLC reissued an “equal weight” rating and issued a $13.00 target price (down from $24.00) on shares of Vitamin Shoppe in a report on Sunday, May 14th. Finally, ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Four equities research analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. Vitamin Shoppe currently has a consensus rating of “Hold” and a consensus target price of $14.38.

The company’s market capitalization is $125.40 million. The stock’s 50 day moving average is $7.60 and its 200 day moving average is $13.77.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the consensus estimate of $0.39 by $0.16. The firm had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business’s revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.55 EPS. Analysts anticipate that Vitamin Shoppe, Inc will post $0.79 earnings per share for the current year.

In other Vitamin Shoppe news, Director John D. Bowlin bought 40,000 shares of the stock in a transaction that occurred on Friday, August 25th. The shares were acquired at an average price of $5.50 per share, with a total value of $220,000.00. Following the completion of the purchase, the director now directly owns 56,028 shares in the company, valued at approximately $308,154. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.07% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of VSI. BNP Paribas Arbitrage SA boosted its position in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its position in shares of Vitamin Shoppe by 18.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock worth $110,000 after purchasing an additional 1,440 shares in the last quarter. Mason Street Advisors LLC lifted its position in shares of Vitamin Shoppe by 7.0% during the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after purchasing an additional 366 shares in the last quarter. Wolverine Trading LLC acquired a new position in shares of Vitamin Shoppe during the second quarter worth approximately $131,000. Finally, UBS Asset Management Americas Inc. lifted its position in shares of Vitamin Shoppe by 17,041.4% during the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock worth $140,000 after purchasing an additional 11,929 shares in the last quarter. 96.86% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe, Inc (VSI) Stock Price Up -5.7%” was originally published by BBNS and is the sole property of of BBNS. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://baseballnewssource.com/markets/vitamin-shoppe-inc-vsi-stock-price-up-5-7/1605493.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with our FREE daily email newsletter.

 


Latest News

Bryce Harper Hoping to Return Monday from Knee Injury
Bryce Harper Hoping to Return Monday from Knee Injury
American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?


Leave a Reply

 
© 2006-2017 BBNS.